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Damaged tissues release glutamate and other chemical mediators for several hours.
These chemical mediators contribute to modulation of pruritus and pain. Herein,
we investigated the effects of long-term activation of excitatory glutamate receptors
on functional expression of transient receptor potential vaniloid type 1 (TRPV1) in
dorsal root ganglion (DRG) neurons and then on thermal pain behavior. In order
to detect the TRPV1-mediated responses in cultured DRG neurons, we monitored
intracellular calcium responses to capsaicin, a TRPV1 agonist, with Fura-2. Long-term
(4 h) treatment with glutamate receptor agonists (glutamate, quisqualate or DHPG)
increased the proportion of neurons responding to capsaicin through activation of
metabotropic glutamate receptor mGluR1, and only partially through the activation
of mGluR5; engagement of these receptors was evident in neurons responding
to allylisothiocyanate (AITC), a transient receptor potential ankyrin type 1 (TRPA1)
agonist. Increase in the proportion was suppressed by phospholipase C (PLC),
protein kinase C, mitogen/extracellular signal-regulated kinase, p38 mitogen-activated
protein kinase or transcription inhibitors. Whole-cell recording was performed to record
TRPV1-mediated membrane current; TRPV1 current density significantly increased
in the AITC-sensitive neurons after the quisqualate treatment. To elucidate the
physiological significance of this phenomenon, a hot plate test was performed.
Intraplantar injection of quisqualate or DHPG induced heat hyperalgesia that lasted for
4 h post injection. This chronic hyperalgesia was attenuated by treatment with either
mGluR1 or mGluR5 antagonists. These results suggest that long-term activation of
mGluR1/5 by peripherally released glutamate may increase the number of neurons
expressing functional TRPV1 in DRG, which may be strongly associated with chronic
hyperalgesia.
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INTRODUCTION
Inflammation and peripheral nerve injury cause release of
glutamate and other neurotransmitters/chemical mediators
from sensory neurons, glia, and damaged cells in the spinal
cord and peripheral tissue in rodents (Omote et al., 1998;
Lawand et al., 2000; Liu and Salter, 2010; Miller et al.,
2011). These mediators elicit firing in nociceptive neurons
resulting in the induction of inflammatory and neuropathic
pain. A similar phenomenon has been reported in humans:
glutamate concentration in the synovial fluid of synovitis patients
was 54 times higher than in non-arthritic control subjects
(McNearney et al., 2000).
Immunohistochemical studies have shown that sensory
neurons express various glutamate receptors, such as
N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-
5-methylisoxazole-4-propionic acid (AMPA) receptors in
rat glabrous skin (Carlton et al., 1995). In addition, group
I metabotropic glutamate receptors (mGluRs) consisting
of two subtypes, mGluR1 and mGluR5, are also expressed
in cell bodies of dorsal root ganglion (DRG) neurons and
unmyelinated afferents in peripheral tissue (Bhave et al.,
2001). Systemic injection of an mGluR1/5 agonist leads to an
increase in sensitivity to noxious heat, or thermal hyperalgesia,
while selective mGluR1 or mGluR5 antagonists attenuate
inflammatory pain (Bhave et al., 2001; Zhou et al., 2001).
Recent studies indicate that mGluR5 in DRG neurons
contributes to activating and/or sensitizing transient receptor
potential vaniloid type 1 (TRPV1) channel. TRPV1 channel
is activated by capsaicin, noxious heat (>43◦C), low pH or
various lipids, resulting in sensitization of sensory neurons in
acute pain. TRPV1 activation via mGluR5 has been shown to
produce an elevation in intracellular calcium concentration in
a small number of rat and mouse DRG neurons (Crawford
et al., 2000; Hu et al., 2002; Kim et al., 2009). TRPV1
activation is mediated by the production of prostaglandins via
the phospholipase C (PLC) cascade in peripheral terminals
of DRG neurons (Hu et al., 2002) and the production of
diacylglycerol in central terminals (Kim et al., 2009). In addition,
our previous work has revealed that mGluR5 biphasically
modulates the intracellular calcium response induced by
capsaicin, a TRPV1 agonist, in DRG neurons; mGluR5 activation
potentiates the TRPV1-mediated intracellular calcium response,
whereas subsequent cessation of mGluR5 activation depresses it,
thus contributing to heat hyper- and hypoalgesia (Masuoka et al.,
2015a,b).
Previous studies on the activation of mGluR5 receptors
in the context of pain or inflammation have focused on
short-term activation for a period of 5–20 min. However,
glutamate remains elevated for much longer periods during
inflammation. For example, a recent microdialysis study revealed
that inflammation induced by formalin elevated extracellular
glutamate concentration in the hind paw for over 3 h (Omote
et al., 1998). In the present study, we show the long-term effects
of group I mGluRs on DRG neurons. In particular, it was tested
whether the proportion of functional TRPV1-expressing neurons
are changed, thereby contributing to chronic heat hyperalgesia.
MATERIALS AND METHODS
All animal procedures were approved by the Ethics Committee
of Kanazawa Medical University and animals were treated
humanely, in accordance with the ‘‘Guiding Principles for the
Care and Use of Laboratory Animals’’ set by the Japanese
Pharmacological Society.
Preparation of Primary Cultures
Culture preparation was conducted as described previously
(Masuoka et al., 2015b). Six- to fourteen-day-old C57BL/6J mice
purchased from SLC (Shizuoka, Japan) were anesthetized with
inhalation of isoflurane (Escainr, Mylan Inc., Cecil Township,
PA, USA). DRG were rapidly dissected in ice-cold Ca2+/Mg2+-
free artificial cerebrospinal fluid (ACSF: 138.6 mM NaCl,
3.35 mM KCl, 21 mM NaHCO3, 9.9 mM glucose, 0.6 mM
NaH2PO4, 2.5 mM CaCl2, and 1 mM MgCl2) gassed with a
mixture of 95% O2 and 5% CO2 (pH 7.4). DRG neurons were
dissociated following treatment with 0.1% type II collagenase
(240–265 U/mg; Worthington Biochemical Co., Lakewood,
NJ, USA), 0.1% trypsin (Gibco, San Diego, CA, USA), and
0.01% DNase I (Sigma, St. Louis, MO, USA) in Ca2+/Mg2+-
free ACSF and shaken (35 cycle/min) in a water bath at
37◦C for 30 min. Cells were gently triturated in Dulbecco’s
Modified Eagle Medium (DMEM; Sigma) containing 10%
horse serum (Gibco), 5% fetal calf serum (Gibco), and 1%
penicillin-streptomycin (Wako, Osaka, Japan). Dispersed cells
were passed through a 100-µm Cell Strainer (BD Biosciences,
San Jose, CA, USA) and the filtered cells were seeded on
glass coverslips (13-mm diameter) coated with poly-L-lysine
(Matsunami Glass Ind., Osaka, Japan). Calcium imaging and
whole-cell patch clamp recording were performed 24–48 h after
dissociation.
Calcium Imaging
Changes in intracellular calcium were measured with a
fluorescent calcium indicator, as described previously (Yoshida
et al., 2012; Masuoka et al., 2015b). For microscopic fluorometric
measurement, cultured DRG neuronal cells were washed twice
with ACSF and incubated for 45 min in the CO2 incubator
(37 ± 2◦C) in a solution of 3 µM of Fura-2-acetoxymethyl
ester (Fura-2 AM; Dojindo Laboratories, Kumamoto, Japan) and
0.005% Cremophor EL (Sigma). After incubation, cells were
washed in ACSF for 30 min and culture dishes were placed
on the stage of an inverted microscope (ECLIPSE TE 300,
Nikon, Tokyo, Japan) equipped with a 20× S-fluor objective.
Fluorescence images were recorded and analyzed using a video
image analysis system (ARGUS/HiSCA, Hamamatsu Photonics,
Hamamatsu, Japan). Experimental agents were dissolved in
ACSF and delivered by incubation in the CO2 incubator and/or
continuous perfusion in the recording chamber (2 mL/min) with
a peristaltic pump. Image pairs were captured at 10 s intervals.
Fura-2 fluorescence was recorded at an emission wavelength of
510 nm by exciting Fura-2 at 340 and 380 nm. The 340 to 380 nm
fluorescence ratio (F340/F380) was used as a parameter of
intracellular calcium concentration. To prevent the variance of
neuronal population in DRG culture, cultures made from same
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mice at the same time were used in control and comparison
groups in one experiment. Experiments were performed 4–6
times for each drug condition, with simultaneous recording of
20–40 neurons per iteration.
Neurons Viability Assay
To elucidate the neuronal death by glutamatergic drugs, cultured
neurons were stained with a physiological solution containing
0.25% tripan blue (WAKO) for 5 min. Blue-stained and
unstained neurons, which were recognized as dead and live
neurons respectively, were counted in random fields under 200×
magnification (DIAPHOT300, Nikon, Tokyo, Japan).
Whole-Cell Patch Clamp Recording
Cultured neurons were plated onto coverslips, transferred to
the recording chamber, and superfused with ACSF. Neurons
were visually identified using a 60× microscope objective
(DIAPHOT300, Nikon, Tokyo, Japan). Pipettes for whole-cell
recordings were made from borosilicate glass capillaries (1.5 mM
outer diameter; World Precision Instruments Inc., Sarasota, FL,
USA). Patch pipettes (4–6 MΩ) were filled with an internal
solution containing 120 mM KCH3SO3, 5 mM KCl, 10 mM K-
EGTA, 5 mM Na-HEPES, 3 mMMg-ATP, and 0.4 mM Na-GTP
(pH 7.4). Series resistance was 8–20 MΩ, which was monitored
throughout recording. Membrane currents were recorded in
a whole-cell configuration using an Axopatch-1D amplifier
and pCLAMP 10 software (Axon Instruments, Foster City,
CA, USA), digitized, and stored on a computer disk for off-
line analysis. Capsaicin and allylisothiocyanate (AITC)-induced
current responses were recorded >5 min after the establishment
of whole-cell configuration. Capsaicin current was induced by
perfusion of 1 µM capsaicin for 15 s. More than 5 min after the
capsaicin current disappeared, AITC currents were induced by
perfusion of 500 µM AITC for 30 s. The extracellular solution
was perfused at 3–4 mL/min.
Behavioral Tests
Pain responses to noxious heat stimuli were assessed in 8-
week-old C57BL/6J male mice (body weight; 20–24 g) by hot
plate test. Mice were habituated to placement in experimental
room for at least 30 min and on disconnected hot plate for
15 min before the test. The heated surface of the plate was
kept at a temperature of 52 ± 0.2◦C (Model-DS 37, Ugo Basile,
Comerio, Italy), as measured by a built-in digital thermometer,
and verified by a surface thermometer. Mice were placed on
the hot plate and surrounded by a clear acrylic cage (200-
mm diameter, 130 mm height). The latency to respond was
measured as the time required for the mouse to lick, flick
or bite its hind paw, or jump. After any of these responses,
the mouse was immediately removed from the hot plate and
returned to its home cage. Failure to respond within 20 s was
grounds for removal from the test, a cutoff established to prevent
tissue damage. All drugs were dissolved in saline and injected
at 10 µl/paw. Control mice were injected with saline. Testing
was performed three times in each mouse; 30 min prior to the
intraplantar drug injection, 15 min after drug injection and 4
h after drug injection. To evaluate the changes in latency, the
latency 30 min prior to the drug injection was subtracted from
those observed 15 min, and 4 h after the treatment. Positive and
negative values implied reduction and elevation of noxious heat
sensitivity, respectively.
Drugs
Glutamate, quisqualate, capsaicin, AITC and actinomycin D
were obtained from Sigma-Aldrich (St. Louis, MO, USA);
7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl
ester (CPCCOEt), 2-methyl-6-(phenylethynyl)pyridine (MPEP),
dihydroxyphenylglycine (DHPG), 2,3-dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) and
1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-
1H-pyrrole-2,5-dione (U73122) were obtained from
Tocris Cookson (Bristol, UK); 2-(2-Amino-3-methoxyphenyl)-
4H-1-benzopyran-4-one (PD98059) were obtained from Wako
(Osaka, Japan); 3-[3-[2,5-Dihydro-4-(1-methyl-1H-indol-3-yl)-
2,5-dioxo-1H-pyrrol-3-yl]-1H-indol-1-yl]propyl carbamimido
thioate (Ro31–8220) and 4-[5-(4-Fluorophenyl)-2-[4-
(methylsulfonyl)phenyl]-1H-imidazol-4-yl] pyridine (SB20
3580) were obtained from Enzo Life Sciences (East Farmingdale,
NY, USA). For calcium imaging, capsaicin (0.5 µM), AITC
(200 µM), glutamate (3, 10 and 30 µM), quisqualate (10 µM),
NBQX (10 µM), CPCCOEt (100 µM), MPEP (50 µM), DHPG
(50 µM), U73122 (2 µM), Ro 31–8220 (100 nm), PD98059
(50 µM), SB203580 (1 µM), and actinomycin D (5 µg/mL) were
dissolved in ACSF. For whole-cell recording, capsaicin (1 µM),
AITC (500 µM), and quisqualate (10 µM) were dissolved in
ACSF. In the hot plate test, quisqualate (1 and 2 mM), DHPG (1
and 3 mM), CPCCOEt (1.25 mM), MPEP (2.5 mM), PD98059
(500 µM), and SB203580 (10 µM) were dissolved in 0.9% saline
containing 10% DMSO.
Statistical Analysis
Data were analyzed with SigmaPlot 13.0 Software (Systat
Software Inc., San Jose, CA, USA). Results are expressed as
mean ± standard error of the mean (SEM). The number of
the cells examined are represented by ‘‘n’’. Parametric and non-
parametric data were assessed using the one-way analysis of
variance (ANOVA) and Kruskal–Wallis test, respectively. Chi-
squared tests were used to assess changes in the proportion of
capsaicin-sensitive neurons. A p-value of < 0.05 was considered
statistically significant.
RESULTS
Long-Term Activation of mGluR1/5
Increases the Proportion of
Capsaicin-Sensitive Neurons
To evaluate the effect of long-term activation of glutamate
receptors on TRPV1 responses, cultured DRG neurons were
incubated for 4 h in ACSF containing glutamate (30 µM) or
quisqualate (10 µM), AMPA receptor and mGluR1/5 agonist
(Figure 1A). TRPV1-mediated responses were induced by
perfusion of 0.5 µM capsaicin, a TRPV1 agonist. Responses
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FIGURE 1 | Effects of long-term application of glutamate and quisqualate on capsaicin-induced intracellular calcium elevation. (A) Experimental design
for the recording of capsaicin-induced intracellular calcium elevation after long-term application of glutamate and quisqualate using Fura-2 AM dye. Representative
images of F340/F380 ratio before and after capsaicin (cap; 0.5 µM) and KCl (50 mM) perfusion using Fura-2 AM in (B) control and (C) quisqualate-treated neurons.
(D) The cumulative curve of calcium response induced by capsaicin in dorsal root ganglion (DRG) neurons in 30 µM glutamate- (closed circles) and 10 µM
quisqualate-treated groups (closed triangles). The X axis represents changes observed in F340/F380 by capsaicin in each recorded neuron. The Y axis represents
the cumulative frequency of neurons arranged in ascending order of capsaicin responses. A vertical dashed line represents x = 0. (E) The change in the proportion of
capsaicin-sensitive (gray) and -insensitive (white) neurons. (F) Bar graph shows magnitude of capsaicin-induced intracellular Ca2+ responses normalized to KCl.
Values are represented as mean ± SEM of whole capsaicin-sensitive neurons in each group. (G) Changes in the percentage of viable neurons after glutamate or
quisqualate treatment. ∗∗p < 0.01, ∗∗∗p < 0.001 against control.
were assessed by measuring changes in intracellular calcium
concentration with Fura-2 AM. Perfusion of capsaicin caused
clear intracellular calcium elevation in a subset of DRG neurons
(Figure 1B). Long-term exposure to quisqualate appeared
to produce an increase in the proportion of DRG neurons
sensitive to capsaicin (Figure 1C). Figure 1D shows the
changes in the cumulative curve for intracellular calcium
responses induced by capsaicin after glutamate or quisqualate
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treatment. In the figure, the Y axis represents the cumulative
frequency of recording neurons arranged in ascending order
to capsaicin responses (∆F340/F380). In control group, more
than half of the DRG neurons (54.2%) showed little to no
response to capsaicin (∆F340/F380 ratio < 0.15). However,
glutamate and quisqualate treatment increased the proportion of
capsaicin-sensitive neurons to 72.0 and 67.9%, respectively.
Data are summarized in Figure 1E. The proportion of
capsaicin-sensitive neurons significantly increased after
treatment with glutamate (30 µM; 67 out of 93 neurons,
72.0%, p < 0.001 compared to control group) or quisqualate
(10 µM; 55 out of 81 neurons, 67.9%, p < 0.01), while 76
out of 166 neurons (45.8%) responded to capsaicin in control
DRG neurons. This increase occurred in a concentration-
dependent manner after treatment with glutamate (3–30 µM,
Figure 1E). Although we analyzed the magnitude of capsaicin-
induced maximal response normalized to KCl, there was no
significant difference in the amplitudes for either of ligand
concentration (p = 0.069: Figure 1F). We performed tripan
blue staining after 30 µM glutamate or 10 µM quisqualate
treatment for 4 h (Figure 1G). Long-term treatment with
these drugs did not cause neuronal death in the DRG
culture.
In the next experiment, DRG neurons were treated with
10 µM quisqualate for 4 h, followed by recording capsaicin
responses in the absence of quisqualate (Figure 2A). An
increase in proportion of capsaicin-sensitive neurons was
observed even after the washout of quisqualate (Figure 2B). The
increased proportion of capsaicin-sensitive neurons associated
with quisqualate (from 47.5% in control to 67.7% following
quisqualate application) was significantly antagonized by
treatment with 100 µM of the selective mGluR1 antagonist
CPCCOEt, (78 out of 155 neurons, 50.3%, p < 0.01), but
not by 50 µM of the selective mGluR5 antagonist MPEP
(90 out of 157 neurons, 57.32%, p = 0.177; Figure 2B).
However, treatment with NBQX (10 µM), a selective AMPA
receptor antagonist, did not affect the quisqualate-related
increase in capsaicin-sensitive neurons (95 out of 145
neurons, 65.5%, p = 1.00). In addition, DHPG, a selective
mGluR1/5 agonist, significantly increased the proportion
of capsaicin-sensitive neurons (95 out of 123 neurons,
77.2%, p < 0.01; Figure 2B). These results indicate that the
increase in proportion of capsaicin-sensitive cells was caused
by mGluR1 activation, and only partially by activation of
mGluR5.
Increases in the Proportion of
Capsaicin-Sensitive Neurons by mGluR1/5
Activation was Mediated by PLC, PKC,
MEK and p38 MAPK
Metabotropic glutamate receptors 1/5 are involved in numerous
signaling pathways. The increase in the proportion of capsaicin-
sensitive neurons induced by quisqualate was suppressed by
treatment with 2 µM U73122 (control; 61 out of 131 neurons,
46.6% vs. quisqualate; 48 out of 95 neurons, 50.5%, p = 0.650),
a PLC inhibitor, or 100 nm Ro31–8220 (control; 42 out of
98 neurons, 42.9% vs. quisqualate; 65 out of 145 neurons, 44.8%,
p = 0.864), a protein kinase C (PKC) inhibitor (Figure 2C). In
addition, the quisqualate-induced increase in capsaicin-sensitive
neurons was inhibited by 50 µM PD98059 (control; 35 out
of 75 neurons, 46.7% vs. quisqualate; 35 out of 84 neurons,
41.7%, p = 0.636), a mitogen/extracellular signal-regulated kinase
(MEK) inhibitor, or 1 µM SB203580 (control; 70 out of
147 neurons, 47.6% vs. quisqualate; 73 out of 139 neurons, 52.5%,
p = 0.478), a p38 mitogen-activated protein kinase (MAPK)
inhibitor. To elucidate the contribution of extracellular calcium
influx, quisqualate was applied under zero calcium conditions.
However, it was impossible to maintain cultured DRG neurons
for 4 h. Therefore, DRG neurons were treated with quisqualate in
a low calcium solution (0.25 mM) for 4 h, followed by capsaicin
at normal concentration of calcium (2.5 mM). Consequently, a
quisqualate-induced increase in capsaicin-sensitive neurons was
observed (control; 35 out of 78 neurons, 44.9% vs. quisqualate;
70 out of 115 neurons, 60.9%, p < 0.05). Therefore, it is
suggested that long-term application of mGluR1/5 activates
PLC, PKC, MEK and p38 MAPK irrelevant to extracellular
calcium influx, producing an increase in capsaicin-sensitive
neurons.
Activation of mGluR1/5 Increases the
Proportion of Capsaicin-Sensitive Neurons
in a Time-Dependent Manner
To examine the time-dependency of the observed increases in
the proportion of capsaicin-sensitive neurons, 10µMquisqualate
was applied to the DRG culture for 1–4 h (Figure 3A).
Quisqualate time-dependently increased number of capsaicin-
sensitive neurons, and the increases became significant for drug
application durations lasting over 2 h (51 out of 85 neurons,
60.0%, p < 0.05; Figure 3B). This increase in the proportion
of capsaicin-sensitive neurons was sustained even after 2 h of
washes and incubation in the absence of quisqualate (67 out of
122 neurons, 54.9%, p < 0.05; Figure 3B). We next examined
whether the observed increase in capsaicin-sensitive neurons
was related to gene expression. Actinomycin D (5 µg/mL), a
transcription inhibitor, completely inhibited the quisqualate-
induced increase in capsaicin-sensitive neurons (actinomycin
D alone: 48 out of 110 neurons, 43.6%, vs. actinomycin
D + quisqualate: 34 out of 93 neurons, 36.6%; p = 0.379;
Figure 3C).
Increases in the Proportion of
Capsaicin-Sensitive Neurons in Transient
Receptor Potential Ankyrin Type 1
(TRPA1)-Expressing Neurons
TRPA1 as well as TRPV1 are recognized as multiple irritant
sensors in the sensory neuron that contribute to the pain
response (Guimaraes and Jordt, 2007; Zurborg et al., 2007).
Recent studies revealed that TRPA1 interacts with TRPV1 and
contributed to the development of inflammatory pain (Akopian,
2011). To clarify the relationship with TRPA1-positive neurons
in the increase of the functional TRPV1-expressing neurons
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FIGURE 2 | Effects of selective glutamatergic receptors antagonists and intracellular signaling pathway inhibitors on quisqualate-induced increase in
capsaicin-sensitive neurons. (A) Experimental design for the recording of capsaicin-induced calcium elevation. (B) The change in the proportion of
capsaicin-sensitive (gray) and -insensitive (white) neurons in presence of selective glutamate receptor inhibitors with quisqualate. (C) The change in the proportion of
capsaicin sensitive (gray) and insensitive (white) neurons in the presence of intracellular signaling pathway inhibitors with quisqualate. ∗p < 0.05, ∗∗p < 0.01 against
control. ##p < 0.01 against quisqualate-treated alone.
population, we examined the proportion of capsaicin-sensitive
neurons in TRPA1-expressing neurons before and after chronic
application of quisqualate. To identify DRG neurons expressing
TRPA1, AITC (a TRPA1 agonist) was perfused before capsaicin
application (Figure 4A). Figure 4B shows the representative
calcium mobilization detected with Fura-2 loaded in DRG
neurons. Application of AITC (200 µM) and/or capsaicin
(0.5 µM) induced intracellular calcium elevation in a distinct
population of DRG neurons. The proportions of neurons that
responded to AITC and/or capsaicin are shown in Figure 4C.
Treatment with quisqualate for 4 h increased the proportion
of capsaicin-sensitive neurons from 45.0% (control; 68 out of
151 neurons) to 59.5% (quisqualate; 97 out of 163 neurons,
p < 0.05), in contrast, there are no significant changes in
the proportion of AITC-sensitive neurons (control; 13.9% vs.
quisqualate; 18.4%, p = 0.34). Among the neurons that responded
to AITC, the increase in the capsaicin-sensitive population
was drastic (23.8%; 5 out of 21 neurons to 73.3%; 22 out of
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FIGURE 3 | Time-dependent increase in capsaicin-sensitive neurons
induced by quisqualate is blocked by a transcription inhibitor.
(A) Experimental design for the recording of capsaicin (cap; 0.5 µM)-induced
calcium elevation to determine time-dependency of quisqualate effect.
(B) Effects of quisqualate treatment duration on the proportion of
capsaicin-sensitive (gray) and -insensitive (white) neurons. (C) Change in the
proportion of capsaicin-sensitive (gray) and -insensitive (white) neurons after
treatment of quisqualate (4 h) in presence of actinomycin D. ∗p < 0.05 against
control. NS, non-significant.
30 neurons, p< 0.01). These results implicate that the increase in
capsaicin-sensitive population was mainly derived from AITC-
sensitive neurons.
Long-Term Application of Quisqualate
Increases Capsaicin-Induced Current
Density in AITC-Sensitive Neurons
To identify changes in the current density of TRPV1 after
long-term activation of mGluR1/5, capsaicin -induced current
were measured in AITC-sensitive and -insensitive neurons after
quisqualate treatment for 4 h (Figure 5). Whole-cell recordings
were conducted on cultured DRG neurons, and the membrane
potential was held at −70 mV. Capsaicin at a concentration
of 1 µM was rapidly perfused into the recording chamber for
15 s and then washed out with ACSF for more than 2 min.
To check AITC responsiveness, 500 µM AITC was perfused
into the chamber for 30 s. Representative recordings from
control and quisqualate-treated DRG neurons are shown in
Figures 5A,B, respectively. Although the current response to
capsaicin in AITC-sensitive DRG neurons tends to be smaller
than in AITC-insensitive DRG neurons (Figure 5A), quisqualate
seems to increase the current response of capsaicin in AITC-
sensitive neurons (Figure 5B). Quisqualate treatment caused
significant increase in current density induced by capsaicin in
AITC-sensitive neurons (p < 0.05; Figure 5C), but not AITC-
insensitive neurons (p = 0.081; Figure 5C).
Intraplantar Injection of Quisqualate
Causes Hyperalgesia via mGluR Activation
We reported that TRPV1 activation is necessary to pain response
to noxious heat in hot plate test, because 5′-iodoresiniferatoxin, a
selective TRPV1 antagonist inhibits the heat response (Masuoka
et al., 2015b). In a previous report, we showed that quisqualate
at a dose of 4 nmol/paw significantly decreased the latency of
heat response 15 min after the treatment. To test the long-
term activation of mGluR1/5 on noxious heat sensitivity, higher
doses of quisqualate or DHPG were injected into the foot soles
of mice. Hot plate tests were subsequently performed 15 min
and 4 h after the injection (Figure 6A). Fifteen minutes after
quisqualate administration, we observed a significant decrease
in the latency to shake, lick, or jump on the hot plate at
doses of 20 and 40 nmol/paw (p < 0.05; Figure 6B). DHPG
also decreased the latency at doses of 20 and 40 nmol/paw
(p < 0.05). The quisqualate-induced heat hyperalgesia was
abolished by MPEP (25 nmol/paw; p < 0.05) but not by
CPCCOEt (50 nmol/paw; p = 0.986; Figure 6C). Decreased
response latency persisted even 4 h after the quisqualate and
DHPG injection at doses of 40 and 60 nmol/paw, respectively
(p < 0.05; Figure 6D). This effect at 4 h was completely
antagonized by CPCCOEt (p < 0.05) or MPEP (p < 0.05;
Figure 6E). Finally, the effects of PD98059 and SB203580
on quisqualate (40 nmol/paw) induced heat hyperalgesia were
examined. Decreased response latency 4 h after the quisqualate
injection was antagonized by the concurrent injection of
PD98059 (10 nmol/paw; p < 0.05) or SB203580 (0.2 nmol/paw;
p< 0.05, Figure 6G). There was no significant effect on decreased
latency 15 min after the injection by either kinase inhibitor
(Figure 6F).
DISCUSSION
In the present study, we evaluated TRPV1 function by measuring
intracellular calcium responses to capsaicin in cultured DRG
neurons. Application of non-selective glutamatergic receptor
agonists for 4 h increased the proportion of capsaicin-sensitive
neurons. This effect was inhibited by the administration of a
selective mGluR1 antagonist and only partially by an mGluR5
antagonist. These results indicate that long-term activation of
mGluR1 and mGluR5 increase the population of DRG neurons
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FIGURE 4 | Changes in the proportion of allylisothiocyanate (AITC)-sensitive neurons that respond to capsaicin. (A) Experimental design for recording of
AITC (200 µM)- and capsaicin (cap; 0.5 µM)-induced calcium elevation after long-term quisqualate application using Fura-2 AM. (B) Time course of intracellular
calcium responses in control culture. Cell #1; Response to AITC. Cell #2; Response to capsaicin. Cell #3; Response to both AITC and capsaicin. Cell #4; No
response to either AITC or capsaicin. (C) The change in the cell population after long-term application of quisqualate.
expressing functional TRPV1. In addition, this phenomenon is
likely to depend on the expression of TRPV1 and/or proteins
modulating TRPV1 sensitivity such as TRPV1b (Vos et al., 2006),
and A-kinase anchoring protein (Jeske et al., 2009), because the
enhanced neuron recruitment persisted up to 2 h following
cessation of mGluRs activation and was completely inhibited
in the presence of a transcription inhibitor, actinomycin D. It
has been reported that mGluR1/5 activates several intracellular
signaling molecules, phosphatidyl inositol 3 (PI3)-kinase, PKC,
p38 MAPK, striatal-enriched protein tyrosine phosphatase
(STEP), and caspase-3 (O’Riordan et al., 2006; Young et al.,
2008; Chen et al., 2013). Kwon et al. (2014) reported that
TRPV1 expression in DRG neurons is under the control of
p38 MAPK phosphorylation in inflammatory sites. In present
study, we also confirmed that the increase in capsaicin-sensitive
neuron was suppressed by application of PLC, PKC, MEK
and p38 MAPK inhibitors. Therefore, it was suggested that
persistent activation of mGluR1/5 enhanced MEK and p38
MAPK pathways via PLC and PKC activation, resulted in
increased numbers of DRG neurons expressing functional
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 March 2016 | Volume 10 | Article 79
Masuoka et al. Glutamate Regulates Functional TRPV1 Expression
FIGURE 5 | Changes in capsaicin-induced current after long-term treatment with quisqualate. Representative traces of TRPV1 current induced by 1 µM
capsaicin and transient receptor potential ankyrin type 1 (TRPA1) current induced by 500 µM AITC in (A) control and (B) quisqualate-treated DRG neurons. The
membrane potential was held at -70 mV. Top, representative current traces from a neuron responsive to capsaicin, but not AITC. Bottom, traces from a neuron
responsive to both capsaicin and AITC. Scale bars = 500 pA, 30 s. (C) The difference in current density of capsaicin response between control and
quisqualate-treated neurons in AITC-insensitive (left) and AITC-sensitive neurons (right). Box and whisker plots show maximum, minimum, upper and lower quartiles,
and median values. ∗p < 0.05 against control.
TRPV1. Recently, an inflammatory mediator prostaglandin
E2, whose metabotropic receptors EP1–4 were expressed in
DRG neurons, was found to facilitate the amount of TRPV1
expression, and the percentage of TRPV1-positive neurons
in the rat neuropathic pain model (Ma et al., 2010). In
addition, activation of the muscarinic acetylcholine receptor M2
decreased the TRPV1 transcript expression, and the number of
capsaicin-responsive neurons in mice DRG (De Angelis et al.,
2014). Therefore, metabotropic receptors might be one of the
important regulators of functional TRPV1 expression in primary
sensory neurons.
Although short-term stimulation of mGluR5 in cultured
DRG neurons potentiated intracellular calcium influx via TRPV1
activation (Masuoka et al., 2015b), the magnitude of individual
intracellular calcium elevation induced by capsaicin was not
changed after long-term activation of glutamate receptors. These
results suggest that the augmentation of the TRPV1-mediated
intracellular response by mGluR5 disappeared after long-term
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FIGURE 6 | Effects of intraplantar injection of glutamatergic drugs in the hot plate test in mice. (A) Experimental design for evaluation of heat sensitivity
15 min and 4 h after drug injection. Changes in latency to shake, lick, or jump after placement on hot plate (52.0 ± 0.2◦C) 15 min (B) or 4 h (D) after injection of
quisqualate and DHPG. Effects of selective mGluR1 and mGluR5 antagonists on quisqualate-induced hyperalgesia 15 min (C) or 4 h (E) after the injection. Effects of
selective MEK and p38 MAPK inhibitors on quisqualate-induced hyperalgesia 15 min (F) or 4 h (G) after the injection. Eight mice were used in each group. Values
represent mean ± SEM. ∗p < 0.05 against control.
stimulation of glutamate receptors. Direct phosphorylation of
TRPV1 via PKC activation has been shown to acutely sensitize
the TRPV1 response (Bhave et al., 2003), which is related to
potentiation of TRPV1-mediated intracellular calcium responses
by short-term stimulation of mGluR5. On the other hand, work
in Xenopus oocytes has shown that the PKC activated bymGluR5
can simultaneously phosphorylate several targets of mGluR5a
(S613, S881, S890 etc.), resulting in mGluR5 desensitization
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(Gereau and Heinemann, 1998). Therefore, the persistent
stimulation of mGluR5 may desensitize acute mGluR5-TRPV1
interaction.
It has been shown that TRPV1 expression in nociceptive
DRG neurons is increase in peripheral neuropathy in rodents
(Hudson et al., 2001; Rashid et al., 2003; Biggs et al., 2007;
Kim et al., 2008). For instance, TRPV1 protein in glabrous
skin is overexpressed in Fabry disease model mice showing
peripheral neuropathy (Lakomá et al., 2014). Kwon et al.
(2014) found that heat hyperalgesia in inflammatory pain
correlates to expression of TRPV1, a molecule working as
a sensor of noxious heat in sensory neurons. Inflammatory
pain induced by complete Freund’s adjuvant increases artemin,
resulting in increase of TRPV1/A1-positive DRG neurons
(Ikeda-Miyagawa et al., 2015). In the present study, we show
that the population of functional TRPV1-expressing neurons
dramatically increased in TRPA1-expressing DRG neurons,
and TRPV1 current density significantly increased in TRPA1-
expressing neurons. The TRPA1 channel was originally proposed
to be a multiple irritant sensor and a noxious cold sensor
(Guimaraes and Jordt, 2007; Zurborg et al., 2007). Thus, it
is compelling that the increase in TRPV1 activity in TRPA1-
positive neurons augments centripetal flow of inputs associated
with pain, even when rodents are exposed to the same noxious
heat stimuli.
TRPV1-TRPA1 interactions in peripheral neurons are
important for adaptive development of inflammatory pain
system (Akopian, 2011). Bandell et al. (2004) reported that one
of the dominant inflammatory mediators, bradykinin, could
indirectly activate TRPA1, likely via production of diacylglycerol.
It has also been known that the pharmacological desensitization
of TRPA1-mediated responses in sensory neurons lacking
TRPV1 is more pronounced than in neuron expressing TRPV1
(Akopian et al., 2007). Taken together, these lines of evidence
suggest that the co-expression of TRPV1 and TRPA1 as a
consequence of mGluR1/5 activation may lead to a slower
desensitization of bradykinin responses in sensory neurons, and
this, in turn, may enhance the development of inflammatory
hyperalgesia.
Disruption of protein kinase A (PKA) or PKC-mediated
TRPV1 sensitization attenuates λ-carrageenan-induced heat
hyperalgesia (Fischer et al., 2013). In addition, increase of
TRPV1/TRPA1 expression induced artemin, a neurotrophic
factor, caused heat hyperalgesia (Ikeda-Miyagawa et al., 2015).
We employed a hot plate test to test whether the increase in
functional TRPV1-expressing neurons induced by mGluR1/5
affects noxious heat sensitivities in the periphery. Intraplantar
injections of high-dose quisqualate induced persistent heat
hyperalgesia for 4 h in the present study. Hyperalgesia 15 min
after the injection was attenuated by mGluR5 antagonist, but
not by mGluR1 antagonist. This result confirms that the acute
phase of hyperalgesia is caused by augmentation of the TRPV1
response by mGluR5, without changes in the proportion of
TRPV1-expressing neurons, as we previously reported (Masuoka
et al., 2015b). On the other hand, hyperalgesia 4 h after
the injection was inhibited by both mGluR1 and mGluR5
antagonists. In addition, the MEK and p38 MAPK inhibitors
selectively attenuated hyperalgesia 4 h after the injection. This
suggests that chronic heat hyperalgesia is related to the increase
in the proportion of functional TRPV1-expressing neurons
following mGluR1 and mGluR5 activation.
In conclusion, long-term activation of mGluR1/5 produces
an increase in the number of DRG neurons expressing
functional TRPV1, which may contribute to the development
of chronic heat hyperalgesia. Persistent elevation of glutamate
release in the periphery may be crucial for understanding
sensory disorders induced by inflammation and tissue
damage.
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